Homeostatic Repopulation by CD28−CD8+ T Cells in Alemtuzumab-Depleted Kidney Transplant Recipients Treated With Reduced Immunosuppression
Open Access
- 15 January 2008
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 8 (2), 338-347
- https://doi.org/10.1111/j.1600-6143.2007.02078.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Recipient Memory-Like Lymphocytes Remain Unresponsive to Graft Antigens After CAMPATH-1H Induction with Reduced Maintenance ImmunosuppressionTransplantation, 2006
- Controlling the Generation and Function of Human CD8+ Memory T Cells In Vitro with ImmunosuppressantsTransplantation, 2006
- Alemtuzumab Induction and Sirolimus Plus Mycophenolate Mofetil Maintenance for CNI and Steroid‐Free Kidney Transplant ImmunosuppressionAmerican Journal of Transplantation, 2005
- Development of tolerogenic strategies in the clinicPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2005
- Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation―Efficacy and Safety at Five YearsAmerican Journal of Transplantation, 2005
- Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or CampathJournal of the American College of Surgeons, 2005
- Immunocompetent T-Cells with a Memory-Like Phenotype are the Dominant Cell Type Following Antibody-Mediated T-Cell DepletionAmerican Journal of Transplantation, 2005
- Homeostatic proliferation is a barrier to transplantation toleranceNature Medicine, 2003
- RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)Transplantation, 2003
- CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1999